The Health Dividend is the return – social, systemic, strategic and economic – when investors prioritise health. It continues and builds on the success of our Long-term Investors in People’s Health (LIPH) Initiative, now backed by more than 50 signatories representing trillions in assets under management.
Better health could add US$12 trillion to global GDP by 2040 – an 8% boost.* But behind every statistic, there’s a human, a family, a community, a workforce. Health impacts everyone.
By illustrating the wide ranging scope of health determinants, The Health Dividend advances the agenda with clear calls to action and practical ways for investors to engage.
Health is no longer just a public good – it’s a systemic imperative. It represents a systemic risk, a strategic opportunity and a moral imperative. Prioritising it is the right thing to do for people, governments and companies – and it’s good for society and markets alike.
This Autumn we will be pushing for health to be prioritised as an investment issue – showing how it impacts and unlocks value across workers, consumers and communities, and culminating in Health Dividend Live at the RSA in London on 13 November. We are stepping up to mobilise, convene and influence investors to make health a priority in decision-making and stewardship.
We are calling on investors to make health an investment priority.
Engage companies, use your vote, demand transparency, shape policy.
Follow our LinkedIn and social channels for updates and useful information to support making health a priority.
If you're an investor thinking of joining the LIPH programme, you can find out more here.
* McKinsey Global Institute, 2020
